Qi Sun

This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Generon (Shanghai) Corporation Ltd., Sap Ag, Sap Se. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Sun. Retrieved from https://idiyas.com/inventor/qi-sun-fde2g9ub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 4)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

2 out of 10

Generon (Shanghai) Corporation Ltd.

Shanghai Emohe Commerce Co., Ltd

patent

Years Active: 2014-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. D1153970 - Pet stairs (2026-10-13),

2. 10786551 - Use of interleukin-22 in the treatment of fatty liver disease (2020-09-29),

3. 9195682 - Integrated analytics on multiple systems (2015-11-24),

4. 8956605 - Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 (2015-02-17),

5. 8775397 - Database access acceleration (2014-07-08),

Title: Innovations and Contributions of Inventor Qi Sun

Introduction

Qi Sun is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical and analytical technologies. With a total of 5 patents, his work focuses on innovative solutions that address critical health issues and enhance data processing systems.

Latest Patents

One of Qi Sun's latest patents is titled "Use of interleukin-22 in the treatment of fatty liver disease." This invention relates to the use of interleukin-22 (IL-22) for treating fatty liver disease by decreasing the levels of transaminases. The patent also outlines the effectiveness of IL-22 in reducing these levels. Another significant patent is "Integrated analytics on multiple systems." This invention provides a federated system for supporting applications to perform analytics. It includes a first distributed system for processing incoming data into a set of data blocks, an in-memory database system for storing these blocks, and a second distributed system for performing analytics on the data blocks.

Career Highlights

Qi Sun has worked with prominent companies, including Generon (Shanghai) Corporation Ltd. and SAP AG. His experience in these organizations has contributed to his expertise in developing innovative technologies.

Collaborations

Qi Sun has collaborated with notable colleagues, including Wen-Syan Li and Yu Liang Huang. Their teamwork has fostered advancements in their respective fields.

Conclusion

Qi Sun's contributions to innovation, particularly in medical treatments and data analytics, highlight his role as a leading inventor. His patents reflect a commitment to improving health outcomes and enhancing technological capabilities.

Profile summary based on public USPTO records.